Epithalon
A longevity peptide being studied for its potential effects on telomeres and cellular aging. Interesting early research but far from proven — approach with healthy skepticism.
This peptide is not FDA-approved for any indication. Human use outside of clinical trials is not recommended.
The basics
- Generic Name
- epithalon (epitalon / epithalone)
- Brand Names
- None (not an approved product)
- Regulatory Status
- Early Research
- Therapeutic Areas
- Endocrine, Immune & Recovery
Wellness Goals
Important: This peptide is not yet FDA-approved
Epithalon has not been approved by the FDA for any use in humans. That means it hasn't gone through the rigorous testing process that confirms a drug is safe and effective. Products sold online have not been evaluated by any regulatory body.
What it does
Epithalon (epithalon (epitalon / epithalone)) is a synthetic peptide that researchers are studying, but it's not yet FDA-approved for any human use. Synthetic tetrapeptide (Ala-Glu-Asp-Gly) that may activate telomerase, the enzyme responsible for maintaining telomere length. Most research comes from a single research group.
The research is still early. Most studies so far are in animals or lab settings, so we don't know for sure how well this translates to real-world results in people.
How it's taken
Subcutaneous injection
How people access it
Only available through research peptide vendors. Not FDA-approved, very limited human evidence, and most research comes from a single lab group. No quality guarantees for commercially available products.
Regulatory Status
Not FDA-approved. A synthetic tetrapeptide studied for potential telomere and longevity effects.
Any use in humans outside of an FDA-authorized clinical trial would require an Investigational New Drug (IND) application. Products marketed as “for research use only” are not legally intended for human administration.
What the Evidence Shows
The evidence base for Epithalon consists primarily of preclinical studies (animal models and in vitro experiments). There are no completed, large-scale, peer-reviewed clinical trials establishing safety or efficacy in humans. The gap between promising animal data and proven human benefit is substantial — many compounds that show effects in animal studies fail to demonstrate safety or efficacy in human trials.
Marketing claims made by online sellers and “peptide clinics” frequently overstate the evidence and omit critical information about risks and unknowns.
Other options to consider
Depending on what you're hoping to achieve, there may be FDA-approved treatments that have been rigorously tested and proven to work. Discuss evidence-based options with your own healthcare provider to find what fits your specific goals.
Browse our full peptide directory to see FDA-approved options that might work for you.
Common Questions
Some lab studies suggest epithalon may activate telomerase, the enzyme that maintains telomere length. But most of this research comes from a single research group, and no large-scale human trials have confirmed these effects. Approach longevity claims with healthy skepticism.
Yes — epithalon, epitalon, and epithalone are all names for the same synthetic tetrapeptide (Ala-Glu-Asp-Gly). The different spellings reflect transliterations from the original Russian research.
The research is very early stage and mostly comes from one research group in Russia. While the concept of telomerase activation is scientifically interesting, the evidence for epithalon specifically is not strong enough to draw conclusions about its effectiveness or safety in humans.
Curious about what IS approved?
Check out FDA-approved peptides that address similar goals — with established safety profiles and real clinical evidence.
See Approved Options